| 注册
首页|期刊导航|中国药物经济学|血必净联合乌司他丁与单用乌司他丁治疗脓毒症的Meta分析

血必净联合乌司他丁与单用乌司他丁治疗脓毒症的Meta分析

李倩 任杰 刘国恩

中国药物经济学Issue(10):9-13,5.
中国药物经济学Issue(10):9-13,5.

血必净联合乌司他丁与单用乌司他丁治疗脓毒症的Meta分析

Meta-Analysis of Xuebijing in Treating Sepsis

李倩 1任杰 2刘国恩1

作者信息

  • 1. 中国药科大学国际医药商学院,江苏南京 211198
  • 2. 中国卫生经济研究中心,北京 100871
  • 折叠

摘要

Abstract

Objective To know the efficacy of Xuebijing injection for the treatment of sepsis.Methods Literatures of RCT(randomized control ed trial) or CCT (clinical control ed trial) were selected to Meta-analysis.Results Four RCTs were included,with 181 patients in the treatment group were given Xuebijing+Ulinastatin+based treatment,181 patients in the control group were given Ulinastatin+basic treatment.Meta-analysis showed that the tumor necrosis factor(TNF-a)levels (WMD = -5.16,95% CI:-11.07~0.76)of experimental group and the control group were not statistical y different,but the interleukin(IL-6) levels(WMD=-57.82,95% CI:-112.12~-3.52),the procalcitonin(PCT) (WMD=-0.53,95% CI:-0.88~-0.19)levels,the average length of stay(WMD=-3.63,95% CI:-4.68~-2.58)and the average duration of mechanical ventilation[WMD=-3.77,95% CI (-4.70,-2.83)]of the treatment group and the control group were statistical y different.Conclusion Current results indicated that the application of Xuebijing injection for the treatment of sepsis provided a lower level of IL-6 and PCT,a shorter length of stay and duration of mechanical ventilation.

关键词

血必净/乌司他丁/脓毒症/Meta分析

Key words

Xuebijing/Ulinastatin/Sepsis/Meta Analysis

分类

医药卫生

引用本文复制引用

李倩,任杰,刘国恩..血必净联合乌司他丁与单用乌司他丁治疗脓毒症的Meta分析[J].中国药物经济学,2014,(10):9-13,5.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文